513 related articles for article (PubMed ID: 30993543)
1. Interaction between phytotherapy and oral anticancer agents: prospective study and literature review.
Clairet AL; Boiteux-Jurain M; Curtit E; Jeannin M; Gérard B; Nerich V; Limat S
Med Oncol; 2019 Apr; 36(5):45. PubMed ID: 30993543
[TBL] [Abstract][Full Text] [Related]
2. Real-life drug-drug and herb-drug interactions in outpatients taking oral anticancer drugs: comparison with databases.
Prely H; Herledan C; Caffin AG; Baudouin A; Larbre V; Maire M; Schwiertz V; Vantard N; Ranchon F; Rioufol C
J Cancer Res Clin Oncol; 2022 Mar; 148(3):707-718. PubMed ID: 33914124
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of polypharmacy, polyherbacy, nutritional supplement use and potential product interactions among older adults living on the United States-Mexico border: a descriptive, questionnaire-based study.
Loya AM; González-Stuart A; Rivera JO
Drugs Aging; 2009; 26(5):423-36. PubMed ID: 19552494
[TBL] [Abstract][Full Text] [Related]
4. Drug-drug interactions in patients treated for cancer: a prospective study on clinical interventions.
van Leeuwen RWF; Jansman FGA; van den Bemt PMLA; de Man F; Piran F; Vincenten I; Jager A; Rijneveld AW; Brugma JD; Mathijssen RHJ; van Gelder T
Ann Oncol; 2015 May; 26(5):992-997. PubMed ID: 25628444
[TBL] [Abstract][Full Text] [Related]
5. Potential Drug-Drug and Herb-Drug Interactions in Patients With Cancer: A Prospective Study of Medication Surveillance.
Ramos-Esquivel A; Víquez-Jaikel Á; Fernández C
J Oncol Pract; 2017 Jul; 13(7):e613-e622. PubMed ID: 28628392
[TBL] [Abstract][Full Text] [Related]
6. Herb-drug interactions in oncology.
Goey AK; Beijnen JH; Schellens JH
Clin Pharmacol Ther; 2014 Apr; 95(4):354-5. PubMed ID: 24646483
[No Abstract] [Full Text] [Related]
7. Relevance of in vitro and clinical data for predicting CYP3A4-mediated herb-drug interactions in cancer patients.
Goey AK; Mooiman KD; Beijnen JH; Schellens JH; Meijerman I
Cancer Treat Rev; 2013 Nov; 39(7):773-83. PubMed ID: 23394826
[TBL] [Abstract][Full Text] [Related]
8. Anticancer agents and phytotherapy: Interactions that are often unrecognized.
Laurent V; Saillard J; Thierry M; Lepelletier A; Fronteau C; Huon JF
J Oncol Pharm Pract; 2021 Mar; 27(2):322-328. PubMed ID: 32356688
[TBL] [Abstract][Full Text] [Related]
9. Real-world data on herb-drug interactions in oncology: A scoping review of pharmacoepidemiological studies.
Lam CS; Koon HK; Ma CT; Au KY; Zuo Z; Chung VC; Cheung YT
Phytomedicine; 2022 Aug; 103():154247. PubMed ID: 35716539
[TBL] [Abstract][Full Text] [Related]
10. [Medicinal plants in cancer patients: current practices and evaluation data].
Huet M
Bull Cancer; 2013 May; 100(5):485-95. PubMed ID: 23695160
[TBL] [Abstract][Full Text] [Related]
11. Drug interactions in oncology.
Beijnen JH; Schellens JH
Lancet Oncol; 2004 Aug; 5(8):489-96. PubMed ID: 15288238
[TBL] [Abstract][Full Text] [Related]
12. Potential risks associated with traditional herbal medicine use in cancer care: A study of Middle Eastern oncology health care professionals.
Ben-Arye E; Samuels N; Goldstein LH; Mutafoglu K; Omran S; Schiff E; Charalambous H; Dweikat T; Ghrayeb I; Bar-Sela G; Turker I; Hassan A; Hassan E; Saad B; Nimri O; Kebudi R; Silbermann M
Cancer; 2016 Feb; 122(4):598-610. PubMed ID: 26599199
[TBL] [Abstract][Full Text] [Related]
13. Polypharmacy in elderly patients with cancer: clinical implications and management.
Lees J; Chan A
Lancet Oncol; 2011 Dec; 12(13):1249-57. PubMed ID: 21741307
[TBL] [Abstract][Full Text] [Related]
14. A pharmacist-led medication assessment used to determine a more precise estimation of the prevalence of complementary and alternative medication (CAM) use among ambulatory senior adults with cancer.
Nightingale G; Hajjar E; Guo K; Komura S; Urnoski E; Sendecki J; Swartz K; Chapman A
J Geriatr Oncol; 2015 Sep; 6(5):411-7. PubMed ID: 26277113
[TBL] [Abstract][Full Text] [Related]
15. Potential of chemotherapy-herb interactions in adult cancer patients.
McCune JS; Hatfield AJ; Blackburn AA; Leith PO; Livingston RB; Ellis GK
Support Care Cancer; 2004 Jun; 12(6):454-62. PubMed ID: 14991387
[TBL] [Abstract][Full Text] [Related]
16. Adverse interactions between herbal and dietary substances and prescription medications: a clinical survey.
Bush TM; Rayburn KS; Holloway SW; Sanchez-Yamamoto DS; Allen BL; Lam T; So BK; Tran de H; Greyber ER; Kantor S; Roth LW
Altern Ther Health Med; 2007; 13(2):30-5. PubMed ID: 17405676
[TBL] [Abstract][Full Text] [Related]
17. [Natural remedies--self care at your own risk! Danger of unknown adverse effects and interactions with "common" medications].
Peterson C
Lakartidningen; 2005 Oct 31-Nov 6; 102(44):3200-1. PubMed ID: 16329448
[No Abstract] [Full Text] [Related]
18. [Natural remedies and hormone preparations--potential risk for breast cancer patients. A study surveys the use of agents which possibly counteract with the treatment].
Malekzadeh F; Rose C; Ingvar C; Jernström H
Lakartidningen; 2005 Oct 31-Nov 6; 102(44):3226-8, 3230-1. PubMed ID: 16329453
[TBL] [Abstract][Full Text] [Related]
19. Herb digoxin interactions.
Cheng TO
Int J Cardiol; 2006 Jun; 110(1):93. PubMed ID: 16168502
[No Abstract] [Full Text] [Related]
20. Herbal medicines safety concerns in patients with cancer.
Bagcchi S
Lancet Oncol; 2016 Jan; 17(1):e10. PubMed ID: 26670091
[No Abstract] [Full Text] [Related]
[Next] [New Search]
